- Home
- CDNA vs BLND Comparison
CDNA vs BLND Comparison
Compare CDNA & BLND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDNA
- BLND
- Stock Information
- Founded
- CDNA 1998
- BLND 2012
- Country
- CDNA United States
- BLND United States
- Employees
- CDNA N/A
- BLND N/A
- Industry
- CDNA Medical Specialities
- BLND EDP Services
- Sector
- CDNA Health Care
- BLND Technology
- Exchange
- CDNA Nasdaq
- BLND Nasdaq
- Market Cap
- CDNA 1.1B
- BLND 946.9M
- IPO Year
- CDNA 2014
- BLND 2021
- Fundamental
- Price
- CDNA $22.94
- BLND $3.99
- Analyst Decision
- CDNA Buy
- BLND Buy
- Analyst Count
- CDNA 8
- BLND 8
- Target Price
- CDNA $26.43
- BLND $4.86
- AVG Volume (30 Days)
- CDNA 823.5K
- BLND 2.9M
- Earning Date
- CDNA 02-26-2025
- BLND 03-13-2025
- Dividend Yield
- CDNA N/A
- BLND N/A
- EPS Growth
- CDNA N/A
- BLND N/A
- EPS
- CDNA N/A
- BLND N/A
- Revenue
- CDNA $312,775,000.00
- BLND $156,715,000.00
- Revenue This Year
- CDNA $20.27
- BLND $5.35
- Revenue Next Year
- CDNA $11.76
- BLND $20.75
- P/E Ratio
- CDNA N/A
- BLND N/A
- Revenue Growth
- CDNA 5.26
- BLND N/A
- 52 Week Low
- CDNA $7.42
- BLND $2.08
- 52 Week High
- CDNA $34.84
- BLND $5.53
- Technical
- Relative Strength Index (RSI)
- CDNA 53.43
- BLND 43.79
- Support Level
- CDNA $21.96
- BLND $3.61
- Resistance Level
- CDNA $23.80
- BLND $4.06
- Average True Range (ATR)
- CDNA 1.53
- BLND 0.20
- MACD
- CDNA 0.09
- BLND 0.06
- Stochastic Oscillator
- CDNA 45.88
- BLND 61.38
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.
About BLND Blend Labs Inc.
Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers. It supports and simplifies applications for mortgages, consumer loans, and deposit accounts. Its operating segments are; Blend Platform segment which comprises a suite of products that power the entire origination process from back-end workflows to consumer experience, and the Title segment enables customers to streamline the title, settlement, and closing process at scale for mortgages, home equity lines of credit, and home equity loans. The majority of the revenue for the company is generated from the Blend Platform segment.